Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

261. Oral appliance to treat obstructive sleep apnea has inconclusive effect on blood pressure

Oral appliance to treat obstructive sleep apnea has inconclusive effect on blood pressure Oral appliance to treat obstructive sleep apnea has inconclusive effect on blood pressure ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all. Together. Take advantage of endorsed, discounted business (...) apnea has inconclusive effect on blood pressure Tofool Alghanem DDS, MS . Overview Systematic Review Conclusion Oral appliance (OA) treatment for mild to moderate obstructive sleep apnea (OSA) improves blood pressure (BP) with effects comparable to those reported using CPAP treatment. Critical Summary Assessment Limited (SR) suggests clinically insignificant decrease in BP with oral appliances treating OSA. Evidence Quality Rating Limited Evidence Structured Abstract Clinical Questions: In adult

2014 ADA Center for Evidence-Based Dentistry

262. Oral appliance to treat obstructive sleep apnea has inconclusive effect on blood pressure

Oral appliance to treat obstructive sleep apnea has inconclusive effect on blood pressure Oral appliance to treat obstructive sleep apnea has inconclusive effect on blood pressure ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all. Together. Take advantage of endorsed, discounted business (...) apnea has inconclusive effect on blood pressure Tofool Alghanem DDS, MS . Overview Systematic Review Conclusion Oral appliance (OA) treatment for mild to moderate obstructive sleep apnea (OSA) improves blood pressure (BP) with effects comparable to those reported using CPAP treatment. Critical Summary Assessment Limited (SR) suggests clinically insignificant decrease in BP with oral appliances treating OSA. Evidence Quality Rating Limited Evidence Structured Abstract Clinical Questions: In adult

2014 ADA Center for Evidence-Based Dentistry

263. [Public policies for the coverage of continuous positive airway pressure devices for the treatment of obstructive sleep apnea]

[Public policies for the coverage of continuous positive airway pressure devices for the treatment of obstructive sleep apnea] Politiques publiques de remboursement d'appareils à pression positive continue pour le traitement de l'apnée obstructive du sommeil [Public policies for the coverage of continuous positive airway pressure devices for the treatment of obstructive sleep apnea] Politiques publiques de remboursement d'appareils à pression positive continue pour le traitement de l'apnée (...) obstructive du sommeil [Public policies for the coverage of continuous positive airway pressure devices for the treatment of obstructive sleep apnea] Potvin E, Lance JM, Institut national d'excellence en santé et services sociaux Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Potvin E, Lance JM, Institut national d'excellence en santé et services

2014 Health Technology Assessment (HTA) Database.

264. CPAP, weight loss, or both for obstructive sleep apnea. Full Text available with Trip Pro

CPAP, weight loss, or both for obstructive sleep apnea. Obesity and obstructive sleep apnea tend to coexist and are associated with inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal relation to these abnormalities is unclear.We randomly assigned 181 patients with obesity, moderate-to-severe obstructive sleep apnea, and serum levels of C-reactive protein (CRP) greater than 1.0 mg per liter to receive treatment with continuous positive airway pressure (CPAP (...) and the weight-loss group. In per-protocol analyses, which included 90 participants who met prespecified criteria for adherence, the combined interventions resulted in a larger reduction in systolic blood pressure and mean arterial pressure than did either CPAP or weight loss alone.In adults with obesity and obstructive sleep apnea, CPAP combined with a weight-loss intervention did not reduce CRP levels more than either intervention alone. In secondary analyses, weight loss provided an incremental reduction

2014 NEJM Controlled trial quality: uncertain

265. Cardiovascular Morbidity and Obstructive Sleep Apnea. (Abstract)

Cardiovascular Morbidity and Obstructive Sleep Apnea. 24918377 2014 06 24 2018 12 02 1533-4406 370 24 2014 Jun 12 The New England journal of medicine N. Engl. J. Med. Cardiovascular morbidity and obstructive sleep apnea. 2339-41 10.1056/NEJMe1404501 Basner Robert C RC From the Columbia University College of Physicians and Surgeons, New York. eng Editorial Comment United States N Engl J Med 0255562 0028-4793 9007-41-4 C-Reactive Protein AIM IM N Engl J Med. 2014 Jun 12;370(24):2265-75 24918371 N (...) Engl J Med. 2014 Jun 12;370(24):2276-85 24918372 N Engl J Med. 2014 Jul 10;371(2):189 C-Reactive Protein analysis Cardiovascular Diseases complications Continuous Positive Airway Pressure Female Humans Male Obesity complications Oxygen Inhalation Therapy Sleep Apnea, Obstructive therapy Weight Loss 2014 6 12 6 0 2014 6 12 6 0 2014 6 25 6 0 ppublish 24918377 10.1056/NEJMe1404501

2014 NEJM

266. Sleep apnea and risk of pneumonia: a nationwide population-based study Full Text available with Trip Pro

Sleep apnea and risk of pneumonia: a nationwide population-based study Evidence evaluating the risk of pneumonia in patients with obstructive sleep apnea is limited and mostly focuses on patients who receive continuous positive airway pressure (CPAP) therapy or on pediatric patients. We aimed to explore the risk of incident pneumonia among adults with sleep apnea, either with or without the need of CPAP therapy.From Jan. 1, 2000, we identified adult patients with sleep apnea from the Taiwan (...) National Health Insurance Research Database. A control cohort without sleep apnea, matched for age, sex and comorbidities, was selected for comparison. The 2 cohorts were followed until Dec. 31, 2010, and observed for occurrence of pneumonia.Of the 34,100 patients (6816 study patients and 27,284 matched controls), 2757 (8.09%) had pneumonia during a mean follow-up period of 4.50 years, including 638 (9.36%) study patients and 2119 (7.77%) controls. Kaplan-Meier analysis showed a higher incidence

2014 EvidenceUpdates

267. Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea

of this assessment has been made for the HTA database. Citation Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2014 Authors' conclusions Obstructive sleep apnea (OSA) is a chronic disorder affecting 2% to 4% of adults. Untreated OSA is associated with daytime sleepiness, insomnia, decreased quality of life (QOL), and a host of comorbidities including cardiovascular disease (...) Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality

2014 Health Technology Assessment (HTA) Database.

268. Apnea Risk Evaluation System (ARES Watermark Medical Inc.) for diagnosis of obstructive sleep apnea

Evaluation System (ARES; Watermark Medical Inc.) for diagnosis of obstructive sleep apnea. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2014 Authors' conclusions Obstructive sleep apnea (OSA) is a chronic disorder affecting 2% to 4% of adults. Untreated OSA is associated with daytime sleepiness, insomnia, decreased quality of life, and a host of comorbidities including cardiovascular disease. Risk factors for OSA include anthropometric factors such as obesity, increased neck (...) Apnea Risk Evaluation System (ARES Watermark Medical Inc.) for diagnosis of obstructive sleep apnea Apnea Risk Evaluation System (ARES; Watermark Medical Inc.) for diagnosis of obstructive sleep apnea Apnea Risk Evaluation System (ARES; Watermark Medical Inc.) for diagnosis of obstructive sleep apnea Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Apnea Risk

2014 Health Technology Assessment (HTA) Database.

269. Weight reduction by dietary and lifestyle modifications can be effective in reducing Obstructive Sleep Apnea (OSA) indices among obese OSA subjects.

-analyses, one of three studies (n = 261) and another on six studies (n = 483). Meta-Analysis Key results The authors reported a reduction in the Apnea Hypopnea Index (AHI) (-4.55 events/h, 95 % CI -7.12, -1.98, I(2) = 54.4 %), but found a high level of heterogeneity. (Thomasouli 2013) Evidence Search 1st search (for the 2013 article): "lifestyle"[All Fields] AND "obstructive sleep apnoea"[All Fields] 2nd search (for the 2010 article): "lifestyle"[All Fields] AND "obstructive sleep apnea"[All Fields (...) lifestyle modification of caloric intake and exercise reduce the severity of OSA as measured by the apena-hypopnea index (AHI) compared to no treatment? Clinical Bottom Line Based on one RCT and a systematic review with meta-analysis, diet and exercise is effective in reducing AHI indices and severity of obstructive sleep apnea. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Tuomilehto/2010 81 patients

2014 UTHSCSA Dental School CAT Library

270. More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome

More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all (...) * Associated Topics More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome Thikriat Al-Jewair BDS, MSc, FRCD (C) . Overview Systematic Review Conclusion Maxillomandibular advancement (MMA) is the most successful surgical therapy, as an alternative to lifelong ventilation therapy, in the treatment of obstructive sleep apnea syndrome (OSAS). Critical Summary Assessment A limited-quality of limited heterogeneous evidence suggests that MMA

2014 ADA Center for Evidence-Based Dentistry

271. More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome

More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all (...) * Associated Topics More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome Thikriat Al-Jewair BDS, MSc, FRCD (C) . Overview Systematic Review Conclusion Maxillomandibular advancement (MMA) is the most successful surgical therapy, as an alternative to lifelong ventilation therapy, in the treatment of obstructive sleep apnea syndrome (OSAS). Critical Summary Assessment A limited-quality of limited heterogeneous evidence suggests that MMA

2014 ADA Center for Evidence-Based Dentistry

272. More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome

More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all (...) * Associated Topics More research needed on the role of maxillomandibular advancement in the treatment of obstructive sleep apnea syndrome Thikriat Al-Jewair BDS, MSc, FRCD (C) . Overview Systematic Review Conclusion Maxillomandibular advancement (MMA) is the most successful surgical therapy, as an alternative to lifelong ventilation therapy, in the treatment of obstructive sleep apnea syndrome (OSAS). Critical Summary Assessment A limited-quality of limited heterogeneous evidence suggests that MMA

2014 ADA Center for Evidence-Based Dentistry

273. There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea

There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all. Together. Take (...) There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea Ben Balevi B.Eng, D.D.S., Dip EBHC(Oxford), M.Sc. . Overview Systematic Review Conclusion The efficacy of a mandibular advancement device (MAD) depends on a number of factors, including the severity of obstructive sleep apnea (OSA), the materials and methods used to fabricate the device and the degree of mandibular protrusion. Critical Summary Assessment Evidence from randomized controlled trials

2014 ADA Center for Evidence-Based Dentistry

274. There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea

There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all. Together. Take (...) There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea Ben Balevi B.Eng, D.D.S., Dip EBHC(Oxford), M.Sc. . Overview Systematic Review Conclusion The efficacy of a mandibular advancement device (MAD) depends on a number of factors, including the severity of obstructive sleep apnea (OSA), the materials and methods used to fabricate the device and the degree of mandibular protrusion. Critical Summary Assessment Evidence from randomized controlled trials

2014 ADA Center for Evidence-Based Dentistry

275. There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea

There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing in better oral health for all. Together. Take (...) There is no one mandibular advancement device design that fits all for the management of obstructive sleep apnea Ben Balevi B.Eng, D.D.S., Dip EBHC(Oxford), M.Sc. . Overview Systematic Review Conclusion The efficacy of a mandibular advancement device (MAD) depends on a number of factors, including the severity of obstructive sleep apnea (OSA), the materials and methods used to fabricate the device and the degree of mandibular protrusion. Critical Summary Assessment Evidence from randomized controlled trials

2014 ADA Center for Evidence-Based Dentistry

276. Bilevel positive airway pressure for the treatment of obstructive sleep apnea in adults

of obstructive sleep apnea in adults. Lansdale: HAYES, Inc.. Directory Publication. 2013 Authors' conclusions Bilevel positive airway pressure (BiPAP) for the treatment of obstructive sleep apnea (OSA) is a technological intervention that delivers airflow during sleep to reduce and/or prevent the occurrence of apneas (periods of no breathing). BiPAP is a form of positive airway pressure therapy that delivers airflow at different rates during the inspiration (inhalation) versus expiration (exhalation) phases (...) of breathing. This therapy has been suggested for use in patients who may have trouble exhaling against the continuous flow of air that is delivered by the more commonly prescribed continuous positive airway pressure (CPAP) treatment for OSA. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Adult; Humans; Positive-Pressure Respiration; Sleep Apnea, Obstructive Language Published English Country of organisation United States English summary

2014 Health Technology Assessment (HTA) Database.

277. Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1

Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1 Zostavax zur Pravention von herpes zoster und postherpetischer neuralgie. Deutsche kurzfassung zum gleichnamigen EUnetHTA Bericht [Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA (...) -1] Zostavax zur Pravention von herpes zoster und postherpetischer neuralgie. Deutsche kurzfassung zum gleichnamigen EUnetHTA Bericht [Zostavax for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA core model for rapid relative effectiveness assessment. Pilot-ID: WP-SA-1] Zechmeister-Koss I Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment

2014 Health Technology Assessment (HTA) Database.

278. Sleep medications for adults diagnosed with insomnia: clinical evidence and harms

Sleep medications for adults diagnosed with insomnia: clinical evidence and harms Sleep medications for adults diagnosed with insomnia: clinical evidence and harms Sleep medications for adults diagnosed with insomnia: clinical evidence and harms CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Sleep medications for adults (...) diagnosed with insomnia: clinical evidence and harms. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Reference List. 2013 Authors' conclusions Five systematic reviews and meta-analyses, 19 randomized controlled trials, and eight observational studies were identified regarding potential harms and dependence with the use of sleep medications for adults diagnosed with insomnia. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Adult

2014 Health Technology Assessment (HTA) Database.

279. Retesting patients with sleep apnea: guidelines and recommendations

: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2013 Authors' conclusions One health technology assessment was identified regarding the frequency at which adult or pediatric patients with sleep apnea should be retested after diagnosis. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Predictive Value of Tests; Respiratory Function Tests; Sleep Apnea, Obstructives Language Published English Country of organisation Canada (...) Retesting patients with sleep apnea: guidelines and recommendations Retesting patients with sleep apnea: guidelines and recommendations Retesting patients with sleep apnea: guidelines and recommendations CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Retesting patients with sleep apnea: guidelines and recommendations. Ottawa

2014 Health Technology Assessment (HTA) Database.

280. Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines

of literature identified, only citations published between 2011 and 2013 were included. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Cognitive Therapys; Sleep Initiation and Maintenance Disorders Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada (...) Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made

2014 Health Technology Assessment (HTA) Database.